AT266127B - Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen

Info

Publication number
AT266127B
AT266127B AT658766A AT658766A AT266127B AT 266127 B AT266127 B AT 266127B AT 658766 A AT658766 A AT 658766A AT 658766 A AT658766 A AT 658766A AT 266127 B AT266127 B AT 266127B
Authority
AT
Austria
Prior art keywords
formula
radical
starting materials
compound
alkylidene group
Prior art date
Application number
AT658766A
Other languages
German (de)
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1585465A external-priority patent/CH500216A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of AT266127B publication Critical patent/AT266127B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT658766A 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen AT266127B (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1432269A CH490405A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH962965A CH484172A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung eines neuen Oxazolidinons
CH1585565A CH512504A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidin-2-on-verbindungen
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH505966A CH507271A (de) 1965-07-09 1966-04-06 Verfahren zur Herstellung von neuen Oxazolidin-2-thion-Verbindungen
CH667066 1966-05-06

Publications (1)

Publication Number Publication Date
AT266127B true AT266127B (de) 1968-11-11

Family

ID=27543759

Family Applications (6)

Application Number Title Priority Date Filing Date
AT658766A AT266127B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen
AT636367A AT269137B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate
AT635867A AT268276B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate
AT658866A AT266128B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten
AT587767A AT266129B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von Oxazolidinderivaten und ihren Salzen
AT587667A AT266832B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen

Family Applications After (5)

Application Number Title Priority Date Filing Date
AT636367A AT269137B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate
AT635867A AT268276B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate
AT658866A AT266128B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten
AT587767A AT266129B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von Oxazolidinderivaten und ihren Salzen
AT587667A AT266832B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen

Country Status (11)

Country Link
US (2) US3455946A (US20080094685A1-20080424-C00004.png)
AT (6) AT266127B (US20080094685A1-20080424-C00004.png)
BE (2) BE683867A (US20080094685A1-20080424-C00004.png)
BR (2) BR6681111D0 (US20080094685A1-20080424-C00004.png)
CH (4) CH484172A (US20080094685A1-20080424-C00004.png)
DE (2) DE1670358A1 (US20080094685A1-20080424-C00004.png)
DK (2) DK126116B (US20080094685A1-20080424-C00004.png)
FR (4) FR1503574A (US20080094685A1-20080424-C00004.png)
GB (2) GB1106594A (US20080094685A1-20080424-C00004.png)
NL (2) NL6609640A (US20080094685A1-20080424-C00004.png)
SE (2) SE324775B (US20080094685A1-20080424-C00004.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546231A (en) * 1968-05-03 1970-12-08 Ansul Co Certain 2-(pyridyl-3-thiocarbamoyl-1,3-oxazolidines)
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
IT1109002B (it) * 1977-09-22 1985-12-16 Menarini Sas Derivati del 2 oxazolidone e loro metodi di preparazione
DE3205457A1 (de) * 1982-02-16 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt Oxazolidin-2-one
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
ES8503657A1 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.
JP2008303145A (ja) * 2005-09-22 2008-12-18 Takeda Chem Ind Ltd Ｇｒｋ阻害剤からなる強心薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB834968A (en) * 1957-08-28 1960-05-18 Robins Co Inc A H 5-o-alkoxyphenoxymethyl-2-oxazolidones
NL131194C (US20080094685A1-20080424-C00004.png) * 1963-07-19

Also Published As

Publication number Publication date
NL6609639A (US20080094685A1-20080424-C00004.png) 1967-01-10
AT269137B (de) 1969-03-10
BE683868A (US20080094685A1-20080424-C00004.png) 1967-01-09
SE324571B (US20080094685A1-20080424-C00004.png) 1970-06-08
NL6609640A (US20080094685A1-20080424-C00004.png) 1967-01-10
GB1108538A (en) 1968-04-03
CH484172A (de) 1970-01-15
BR6681113D0 (pt) 1973-12-26
BE683867A (US20080094685A1-20080424-C00004.png) 1967-01-09
GB1106594A (en) 1968-03-20
US3455946A (en) 1969-07-15
CH512504A (de) 1971-09-15
AT268276B (de) 1969-02-10
FR6015M (US20080094685A1-20080424-C00004.png) 1968-05-06
CH507271A (de) 1971-05-15
FR5727M (US20080094685A1-20080424-C00004.png) 1968-01-22
SE324775B (US20080094685A1-20080424-C00004.png) 1970-06-15
DE1670357A1 (de) 1970-10-29
CH490405A (de) 1970-05-15
DK125893B (da) 1973-05-21
AT266832B (de) 1968-12-10
FR1503574A (fr) 1967-12-01
AT266129B (de) 1968-11-11
BR6681111D0 (pt) 1973-12-26
US3480640A (en) 1969-11-25
AT266128B (de) 1968-11-11
DE1670358A1 (de) 1970-10-29
FR5728M (US20080094685A1-20080424-C00004.png) 1968-01-22
DK126116B (da) 1973-06-12

Similar Documents

Publication Publication Date Title
AT266127B (de) Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen
AT391471B (de) Neue derivate von 5-aminomethyl-2-furanmethanol, ihre herstellung und verwendung
DE1212984B (de) Verfahren zur Herstellung von basisch substituierten Cumaronen
DE2152367C2 (de) Verfahren zur Herstellung von 4- Methyl-oxazolen
AT345822B (de) Verfahren zur herstellung von neuen triazolderivaten
AT246339B (de) Verfahren zur Herstellung von neuen p-Alkylbenzyltropiniumderivaten
CH500216A (de) Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH623574A5 (US20080094685A1-20080424-C00004.png)
CH505847A (de) Verfahren zur Herstellung von neuen Oxazolidinderivaten
AT314537B (de) Verfahren zur Herstellung von neuen 1,3,4,9b-Tetrahydro-2H-indeno[1,2-c]pyridinen und ihren Säureadditionssalzen
AT265273B (de) Verfahren zur Herstellung von neuen 2-Oxo-7-phenyl-1,2,3,4,6,7-hexahydro-11bH-benzo[a]-chinolizinen sowie von deren Säureadditions- und quartären Ammoniumsalzen
AT230887B (de) Verfahren zur Herstellung von neuen, acylierten Aminopyridinen und von deren Salzen
AT253494B (de) Verfahren zur Herstellung von neuen Dibenzo[a, d] cycloheptadien-Derivaten
AT227713B (de) Verfahren zur Herstellung von neuen 1,5-Diazacyclooctan-Derivaten
DE1470370C3 (de) Basisch substituierte Pseudoindole und ein Verfahren zu ihrer Herstellung
CH514615A (de) Verfahren zur Herstellung von neuen Oxazolidinderivaten
DE2210650C3 (de) 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
AT227249B (de) Verfahren zur Herstellung neuer Hydrazinverbindungen und deren Salze und Acylierungs produkte
AT212827B (de) Verfahren zur Herstellung neuer 3-Aralkyl-2-tert. aminoalkyl-indene, ihrer Säureadditionssalze, quaternären Ammoniumverbindungen und N-Oxyde
AT267492B (de) Verfahren zur Herstellung von neuen Dibenzocycloheptenderivaten
AT265274B (de) Verfahren zur Herstellung von neuen 2-Oxo-7-phenyl-1,2,3,4,6,7-hexahydro-11bH-benzo[a]-chinolizinen sowie von deren Säureadditions- und quartären Ammoniumsalzen
DE1568253C (de) N substituierte 1,2 Diphenyl 2 acyloxy 3 amino methyl butene
AT314516B (de) Verfahren zur Herstellung neuer α-Phenylfettsäuren und ihrer Salze
CH505852A (de) Verfahren zur Herstellung von neuen Benzoxazepinonen
AT215998B (de) Verfahren zur Herstellung von neuen Hydrazinderivaten